RAF1 Promotes Anlotinib Resistance in Non-Small Cell Lung Cancer by Inhibiting Apoptosis

Analysis of RAF1 expression in NSCLC and its relationship with targeted therapy resistance and apoptosis through bioinformatics methods. Immunohistochemistry was employed to evaluate the relationship between RAF1 expression and anlotinib resistance in NSCLC tissues.